Q: GUD has just invested 20m in their IPO
That is a big commitment from a conservative Jonathan Goodman. I know you don’t like to invest in IPO’s at the onset, and neither do I, but am thinking of buying into this one.
Your thoughts ?
Thanks
Q: You may not be familiar with this company as it's a US-based bio-tech. But, in case you do, ALNY just reported and the results were very good. Yet even before they reported the stock was dropping and is continuing to drop. Any reason why?
Thanks,
Murray
Q: Good morning Peter n your wonderful team,
I sold my J&J shares recently due to the outstanding lawsuits against the company, I think of replacing it with Pfizer. What is your opinion on future of Pfizer’s earnings, growth n dividends, cash flow, pipelines of drugs, balance sheet etc. Or can you please suggest one or two drug companies that will provide some growth plus dividend income?
Q: Hi on july 18th you suggested to Gary IHI And XHE for medical device etf please explain and compare the two ,if you only have funds for one which would you chose thanks
Q: Hi,
What are your thoughts on Merck as an investment, the company’s potential growth and risk? My interest started in Merck because of their immunotherapy drug... Keytruda. Keytruda has eliminated some of my mom’s melanoma tumors and shrinking cancer in two other areas of her body. Other melanoma patients are seeing positive results. Melanoma cannot be treated with chemo. This drug is now being tried on some liver cancers and was initially developed for some types of lung cancer. I really don’t know a lot about this company and would like your opinion.
Thanks,
Kerri
Any reason for continued decline in SP other than the recent financing? How do you feel about the company at this point? Would you add to an existing position?
Q: Hi guys:
I’m down 36 percent on Crh . Should I sell this name and take the remaining money to buy Covalon. Would this be a wise move or a ridiculous move?
Thanks
Mark
Q: I read in a reply to a question about Intelgenx technologies you indicated that insiders owned less than 2%, insiders own close to 18%. Company seems to have a lot of irons in the fire namely exclusivity with Eli Lily for their Cialis drug partnership with Endo/Par for subaxone, 4drug app to be filed by 2018 in collaboration with Insud pharma, approval for migraine drug in Europe,health canada approval for manufacturing site, Alzheimer's trial Maxim group initiating with a 12month us$3 target. I am heavily invested in the company and would love to hear unbiased thoughts on the company in light of the recent developments. Thanks and look forward to ur reply
Q: Johnson and Johnson is a highly rated company. However they are facing a large number of law suits, mostly related to talcum powder. Although the scientific basis for these lawsuits is extremely weak, I am concerned about the legal system in the USA. Would you recommend I keep holding my JNJ shares or sell and invest in something else in the USA? Diversification is not an issue.